Centessa Pharmaceuticals plc shifts focus to ORX750 for sleep disorders after discontinuing SerpinPC. Click here to find out ...

Alkermes (ALKS) announced the initiation of Vibrance-3, a phase 2 clinical study evaluating the safety and efficacy of ALKS 2680 compared to ...

Alkermes plc (Nasdaq: ALKS) today announced the initiation of Vibrance-3, a phase 2 clinical study evaluating the safety and efficacy of ALKS 2680 compared to placebo in adults with idiopathic ...

Stackhouse was diagnosed with narcolepsy during his first year at Georgia, where he started 42 games and won two national ...

The randomised trial saw more than half of patients dosed with Sunosi achieving clinical response to the therapy used to ...

When the NFL suspended Rams wide receiver Drake Stoops two games for violating the league policy on performance-enhancing ...

Taking a gamble by purchasing the rights to an underperforming narcolepsy drug may soon begin paying dividends for Axsome ...

I am delighted to serve as guest editor for the recently published CNS Drugs supplement, focused on key clinical issues for people with narcolepsy and their clinicians with a particular emphasis on ...

Kat Abughazaleh is a dynamic 26-year-old political commentator whos making waves on social media. She is stepping up to run ...

WACC (Weighted Average Cost of Capital): 11.05%, coming from 11.5% cost of equity (about 11% I use for a no-moat stock, but I ...

Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced the appointment of Adam Zaeske as Executive Vice President and Chief Commercial Officer (CCO), effective March 31, 2025. The ...

Before Grace Watson left primary school, she could already drive a tractor and a manual ute - now she's a finalist for Ahuwhenua Young Māori Farmer of the Year.